Clinical impact of leukemic blast heterogeneity at diagnosis in cytogenetic intermediate-risk acute myeloid leukemia.
about
Validation and implementation of a method for microarray gene expression profiling of minor B-cell subpopulations in manDiagnostic work-up of acute myeloid leukemia.Blast cell deficiency of CD11a as a marker of acute megakaryoblastic leukemia and transient myeloproliferative disease in children with and without Down syndrome.Issue highlights--Cytometry part B November 2013.
P2860
Clinical impact of leukemic blast heterogeneity at diagnosis in cytogenetic intermediate-risk acute myeloid leukemia.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Clinical impact of leukemic bl ...... e-risk acute myeloid leukemia.
@en
Clinical impact of leukemic bl ...... e-risk acute myeloid leukemia.
@nl
type
label
Clinical impact of leukemic bl ...... e-risk acute myeloid leukemia.
@en
Clinical impact of leukemic bl ...... e-risk acute myeloid leukemia.
@nl
prefLabel
Clinical impact of leukemic bl ...... e-risk acute myeloid leukemia.
@en
Clinical impact of leukemic bl ...... e-risk acute myeloid leukemia.
@nl
P2093
P2860
P50
P356
P1476
Clinical impact of leukemic bl ...... e-risk acute myeloid leukemia.
@en
P2093
Alexander Schmitz
Eva Birgitte Leinoe
Marianne Hutchings Hoffmann
Martin Boegsted
Olav Jonas Bergmann
Steffen Falgreen Larsen
Suzette Sorensen
Tobias Wirenfeldt Klausen
P2860
P304
P356
10.1002/CYTO.B.20633
P577
2012-02-10T00:00:00Z